The Hematologist

A. Keith Stewart, MB, ChB

Vasek and Anna Maria Polak Professorship in Cancer Research, Dean for Research Scottsdale, AZ
Mayo Clinic in Arizona, Division of Hematology/Oncology, Mayo Clinic
  • Myeloma Highlights of 2014January 13, 2015 | January-February 2015, Volume 12, Issue 1

    A number of publications from 2014 that impact our understanding and treatment of multiple myeloma (MM) stand out. First, insights into the mechanism of action of thalidomide and its analogues came fast and frequently. With more direct therapeutic relevance, the results of the Phase III ASPIRE clinical trial were published. This trial tested the hypothesis that three drugs would be better than two in relapsed MM. Finally, a randomized trial reconfirmed the role of transplantation in MM patients younger than 65 years.

back to top